Public Comment for Rocket Pharmaceuticals Kresladi Access Plan
NOTICE OF 7-BUSINESS DAY PUBLIC COMMENT PERIOD Rocket Pharmaceuticals Access and Affordability Plan for KRESLADI™ California Institute for Regenerative Medicine (CIRM) Pursuant to CIRM’s Intellectual Property Regulations and Access and…